Deeply technical founders.
Building together.

Everyone at Ember intends to run a company — as CEO or board chair. No hierarchy, no career investors, no back office. We loop out to lead the companies we create and bring what we learn back in.

Portrait of Mark DePristo

Mark DePristo

PhD

GATK, DeepVariant, founding CEO of BigHat Biosciences

Scientist, entrepreneur, and technologist with a track record of building influential genomics and AI organizations and turning foundational technical work into broad real-world impact.

Portrait of Pierre Fontanillas

Pierre Fontanillas

PhD

Highly cited scientific leader; 23andMe, Broad Institute

Translational scientist driven by connecting fundamental biology, engineering, and AI to create practical technologies that redefine what is possible in biotechnology.

Portrait of Puneet Batra

Puneet Batra

PhD

Technical leader in AI + bio; Flagship Pioneering, Mirai

Artificial Intelligence leader in biotech. Previously Senior Principal at Flagship Pioneering and Director of Machine Learning at the Broad Institute.

Portrait of Martin Bittner

Martin Bittner

MD DPhil MBA

Serial AI entrepreneur CEO; Redouble.ai, Arctoris

Serial entrepreneur at the intersection of technology and healthcare/ life sciences. Co-Founder & CEO of Redouble AI; previously Co-Founder & CEO of Arctoris.

Portrait of Theresa Tribble

Theresa Tribble

MBA

Commercially focused venture-backed leader; Droplet, Everlywell

Life sciences and diagnostics operator. Former CBO at EverlyWell, founding CEO at Droplet Biosciences. Brings deep experience in commercial strategy and company building.

Portrait of Natalie Weinrauch

Natalie Weinrauch

BS

Life sciences strategy and healthcare investing; Deloitte, Stanford GSB

Life sciences strategist and healthcare investor with a biomedical engineering foundation. Previously Senior Consultant in Deloitte's Life Sciences Strategy & Analytics practice, advising biotech and biopharma on enterprise strategy and R&D operations.

Across the team

  • →Led early work applying AI in the life sciences across multiple subfields.
  • →Three of us have been venture-backed CEOs; two have been senior technical executives.
  • →$200M+ raised directly, and over $500M at companies where the team served as senior executives.